BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,047.15
      0.81%
      US Tech 100
      20,607.20
      1.07%
      Dow Jones
      44,782.00
      -0.29%
      Brent Oil
      71.885
      -0.01%
      Bitcoin
      96,111.26
      0.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CNS Pharmaceuticals Inc (CNSP)

      7. CNS Pharmaceuticals Inc (CNSP) Financials

      CNS Pharmaceuticals Inc

      CNS Pharmaceuticals Inc (CNSP)

      NASDAQ
      0.1119
      -0.0001
      (-0.09%)
      Closed December 02 4:00PM
      Delayed by 15 minutes
      0.1101
      -0.0018
      (-1.61%)
      After Hours: 7:50PM
      Delayed by 15 minutes

      CNS Pharmaceuticals Inc Financial Summary

      The current CNSP market cap is 3.54M. The company's latest EPS is USD -0.5864 and P/E is -0.19.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.03M-4.53M-5.38M-3.55M-2.53M
      Net Income -4.02M-4.52M-5.38M-3.55M-2.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -3.83M-9.46M-14.03M-15.27M-18.87M
      Net Income -3.88M-9.46M-14.04M-15.27M-18.85M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 6.45M2.33M1.7M1.66M2.47M
      Total Liabilities 4M4.07M6.13M6.09M6.76M
      Total Equity 2.45M-1.74M-4.43M-4.43M-4.29M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 7.91M15.85M8.76M13.05M1.7M
      Total Liabilities 311k1.91M2.14M4.92M6.13M
      Total Equity 7.6M13.95M6.62M8.13M-4.43M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -8.23M-11.6M-14.14M-3.19M-4.84M
      Investing N/A -2k-4k N/A N/A
      Financing 2.45M2.46M4.64M3.46M5.79M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.55M-7.32M-13.54M-10.56M-14.14M
      Investing -20k-18k-6k-4k-4k
      Financing 10.26M14.13M4.51M15.61M4.64M

      Stats and Ratios

      Market Cap 3.54M
      Price to Earnings Ratio -0.19
      Price to Sales Ratio 0
      Price to Cash Ratio 6.43
      Price to Book Ratio -0.8
      Dividend Yield -

      Share Statistics

      Shares Outstanding 32.15M
      Average Volume (1 week) 3.41M
      Average Volume (1 Month) 9.19M
      52 Week Change -99.90%
      52 Week High 114.50
      52 Week Low 0.0955
      Spread (Intraday) 0 (4.01%)

      Company Info

      Company Name CNS Pharmaceuticals Inc
      Address 112 north curry street
      carson city, nevada 89703
      Website https://www.cnspharma.com
      Industry pharmaceutical preparations (2834)